Antoinette Anger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Antoinette Anger has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Benoit Leizour
Service Urologie, Clinique Beau Soleil, Montpellier, France
1 shared publication - Brigitte Trétarre
Registre des Tumeurs de l’Hérault, Montpellier, France
1 shared publication - Claire Mulot
Centre de Recherche des Cordeliers, INSERM, Sorbonne University, USPC, University Paris Descartes, University Paris Diderot, EPIGENETEC, Paris, France
1 shared publication EPICAP Study Group
Environmental Epidemiology of Cancer Team 16av. Paul Vaillant Couturier 94807 Villejuif Cédex France
1 shared publication- Emilie Cordina-Duverger
Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France
1 shared publication - Florence Menegaux
Université Paris-Saclay, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France
1 shared publication
Latest Publications
- Open Access
- 29 September 2016
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 1-8
Weight and weight changes throughout life and postmenopausal breast cancer risk: a case-control study in France
Overweight and weight gain throughout adult life have been associated with increased risk of breast cancer after the menopause. However the role of body weight at a young age and of the timing of weight gain over the lifetime in postmenopausal breast cancer is not well documented. We conducted a population-based case-control study on breast cancer in France that included 739 cases and 815 population controls in postmenopausal women. Height, weight at age 20, 40 and 50 as well as weight one year before diagnosis were obtained during in-person interviews. No association between body mass index at the age of 20 years and breast cancer after the menopause was detected. However, we found that postmenopausal breast cancer was associated with weight gain between ages 40 and 50 years (OR per 5 kg/m2 increase in BMI: 1.45 [95%ci 1.06−1.98]). The increased risk of breast cancer associated with weight gain was more consistent in leaner women at age 20, in older postmenopausal women (>65 years), and in women who did not use menopausal hormone therapy. These findings point to the importance of controlling for weight gain in middle aged-women. The role of low body weight in young adulthood in breast cancer risk after the menopause should be further scrutinized.
- 29 September 2016
- Published by Springer Nature in BMC Cancer
- Vol. 16 (1) , 1-8
Open AccessWeight and weight changes throughout life and postmenopausal breast cancer risk: a case-control study in France
Overweight and weight gain throughout adult life have been associated with increased risk of breast cancer after the menopause. However the role of body weight at a young age and of the timing of weight gain over the lifetime in postmenopausal breast cancer is not well documented. We conducted a population-based case-control study on breast cancer in France that included 739 cases and 815 population controls in postmenopausal women. Height, weight at age 20, 40 and 50 as well as weight one year before diagnosis were obtained during in-person interviews. No association between body mass index at the age of 20 years and breast cancer after the menopause was detected. However, we found that postmenopausal breast cancer was associated with weight gain between ages 40 and 50 years (OR per 5 kg/m2 increase in BMI: 1.45 [95%ci 1.06−1.98]). The increased risk of breast cancer associated with weight gain was more consistent in leaner women at age 20, in older postmenopausal women (>65 years), and in women who did not use menopausal hormone therapy. These findings point to the importance of controlling for weight gain in middle aged-women. The role of low body weight in young adulthood in breast cancer risk after the menopause should be further scrutinized.
- Open Access
- 19 February 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 106
Epidemiological study of prostate cancer (EPICAP): a population-based case–control study in France
Prostate cancer is the most common cancer in male in most Western countries, including France. Despite a significant morbidity and mortality to a lesser extent, the etiology of prostate cancer remains largely unknown. Indeed, the only well-established risk factors to date are age, ethnicity and a family history of prostate cancer. We present, here, the rationale and design of the EPIdemiological study of Prostate CAncer (EPICAP), a population-based case–control study specifically designed to investigate the role of environmental and genetic factors in prostate cancer. The EPICAP study will particularly focused on the role of circadian disruption, chronic inflammation, hormonal and metabolic factors in the occurrence of prostate cancer.
- 19 February 2014
- Published by Springer Nature in BMC Cancer
- Vol. 14 (1) , 106
Open AccessEpidemiological study of prostate cancer (EPICAP): a population-based case–control study in France
Prostate cancer is the most common cancer in male in most Western countries, including France. Despite a significant morbidity and mortality to a lesser extent, the etiology of prostate cancer remains largely unknown. Indeed, the only well-established risk factors to date are age, ethnicity and a family history of prostate cancer. We present, here, the rationale and design of the EPIdemiological study of Prostate CAncer (EPICAP), a population-based case–control study specifically designed to investigate the role of environmental and genetic factors in prostate cancer. The EPICAP study will particularly focused on the role of circadian disruption, chronic inflammation, hormonal and metabolic factors in the occurrence of prostate cancer.